EUVIMEDEUVIMED entdecken
Crossref

Delayed total-body [18F]FDG PET/CT demonstrates systemic vascular inflammation after concurrent chemoradiotherapy in patients with head and neck cancer

Guobing Liu, Yasser G Abdelhafez, Brahim Mehadji, Martina Di Franco, Benjamin A Spencer, Siqi Li, Fatma Sen, Jinger Yu Sun, Shyam Rao, Abass Alavi, Hongcheng Shi, Guobao Wang und 1 weitere

European Journal of Nuclear Medicine and Molecular Imaging · 2026-11 · 53 (13) · 7759-7769

DOI: 10.1007/s00259-026-08160-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 05.09.2026. Verfasst von Guobing Liu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, University of California Davis Health, 4860 Y Steet, Sacramento, CA, 95817, USA. gbbliu@health.ucdavis.edu. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Positron Emission Tomography Computed Tomography, Chemoradiotherapy, Head and Neck Neoplasms. Die Arbeit nennt 37 Literaturangaben. Gefördert von: In Vivo Translational Imaging Shared Resources, Fred and Julia Rusch Foundation for Nuclear Medicine Research and Education, United Imaging Health's Fellowship Gift.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To investigate the feasibility of 2-h-delayed total-body [18F]FDG PET/CT for detecting vascular inflammation after concurrent chemoradiotherapy (CCRT) in head-and-neck-cancer (HNC) patients and to exploratorily assess its association with cardiovascular-related events (CVRE). METHODS: Twenty-four HNC patients underwent 2-h total-body [18F]FDG PET/CT before and 3 months after CCRT and were followed for CVRE. Vascular inflammation was evaluated across eleven arterial segments. Slice-based mean standardized uptake values (SUVmean) were normalized to the superior vena cava (SVC) to derive the target-to-background ratio (TBRmean), and segmental averages (avgTBRmean) were calculated. Pre- and post-CCRT avgTBRmean were compared, and the relative difference (RD-avgTBRmean) was analyzed for association with radiation dose and CVRE. RESULTS: Post-CCRT PET demonstrated increased avgTBRmean in all arterial segments, with significant increases in the carotid arteries (left: 1.32 vs 1.20, P < 0.001; right: 1.34 vs 1.24, P = 0.018), subclavian arteries (left: 1.20 vs 1.14, P = 0.022; right: 1.18 vs 1.10, P = 0.019), and infrarenal abdominal aorta (1.08 vs 0.96, P < 0.001). Mean radiotherapy dose correlated with both post-CCRT avgTBRmean (r = 0.289, P = 0.002) and RD-avgTBRmean (r = 0.251, P = 0.008). Patient-based average RD-avgTBRmean was higher in patients with CVRE (12.1% ± 6.7% vs. 4.5% ± 6.5%, P = 0.032). However, no independent association remained after age adjustment. The SUVmean of SVC was comparable between pre- and post-CCRT PET. CONCLUSION: Delayed total-body [18F]FDG PET/CT demonstrated CCRT-related vascular inflammation in HNC patients, suggesting a potential imaging biomarker of treatment-related cardiovascular risk but warrants validation in larger studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fluorodeoxyglucose F18Positron Emission Tomography Computed TomographyChemoradiotherapyHead and Neck NeoplasmsWhole Body ImagingHumansFemaleMaleMiddle AgedAgedInflammationTime FactorsAdultRadiopharmaceuticals

Stichwörter der Autor:innen

2-[18F]-fluoro-2-deoxy-D-glucoseChemotherapyHead-and-neck cancerPositron emission tomographyRadiotherapy

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of Radiology, University of California Davis Health, 4860 Y Steet, Sacramento, CA, 95817, USA. gbbliu@health.ucdavis.edu.
  • Department of Radiology, University of California Davis Health, 4860 Y Steet, Sacramento, CA, 95817, USA.
  • Department of Radiation Oncology, University of California Davis Health, Sacramento, CA, 95817, USA.
  • Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA, 19104, USA.
  • Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.

Förderung

  • In Vivo Translational Imaging Shared Resources
  • Fred and Julia Rusch Foundation for Nuclear Medicine Research and Education
  • United Imaging Health's Fellowship Gift

Zitieren

APA

Liu, G., Abdelhafez, Y. G., Mehadji, B., Di Franco, M., Spencer, B. A., Li, S., Sen, F., Sun, J. Y., Rao, S., Alavi, A., Shi, H., Wang, G., & Nardo, L. (2026). Delayed total-body [18F]FDG PET/CT demonstrates systemic vascular inflammation after concurrent chemoradiotherapy in patients with head and neck cancer. European Journal of Nuclear Medicine and Molecular Imaging, 53(13), 7759-7769. https://doi.org/10.1007/s00259-026-08160-2

Vancouver

Liu G, Abdelhafez YG, Mehadji B, Di Franco M, Spencer BA, Li S, et al. Delayed total-body [18F]FDG PET/CT demonstrates systemic vascular inflammation after concurrent chemoradiotherapy in patients with head and neck cancer. European Journal of Nuclear Medicine and Molecular Imaging. 2026;53(13):7759-7769. doi:10.1007/s00259-026-08160-2

BibTeX
@article{Liu2026,
  author = {Liu, Guobing and Abdelhafez, Yasser G and Mehadji, Brahim and Di Franco, Martina and Spencer, Benjamin A and Li, Siqi and Sen, Fatma and Sun, Jinger Yu and Rao, Shyam and Alavi, Abass and Shi, Hongcheng and Wang, Guobao and Nardo, Lorenzo},
  title = {Delayed total-body [18F]FDG PET/CT demonstrates systemic vascular inflammation after concurrent chemoradiotherapy in patients with head and neck cancer},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2026},
  volume = {53},
  number = {13},
  pages = {7759--7769},
  doi = {10.1007/s00259-026-08160-2}
}
Kostenlos starten →